Orifarm reports progress on top line
Danish pharmaceutical firm Orifarm has reported a 27% increase in its revenue in one year.
by christopher due karlsson, translated by catherine brett
Pharmaceutical firm Orifarm has reported that last year, its revenue increased by 27% compared to the preceding year, to total DKK 10.5bn (USD 1.5bn).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orifarm expands headquarters following huge acquisition
For subscribers
Orifarm ramps up growth plans following USD 703m acquisition
For subscribers
.jpg)
.jpg&w=384&q=75)
